Actively Recruiting
Pharmacokinetic Comparison of HC034S Injection Versus Erbitux in Healthy Male Volunteers Using Randomized Double-Blind Design
Led by HC Biopharma Inc. · Updated on 2026-11-04
92
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a Phase I, randomized, double-blind, parallel-group clinical study to compare the pharmacokinetics of a drug called HC034S injection with Erbitux Cetuximab in healthy male volunteers aged 18 to 46 years. The study aims to evaluate and compare how the body absorbs and processes these two drugs, which are administered intravenously. This investigation is sponsored by HC Biopharma Inc. and focuses on understanding drug behavior rather than treatment effectiveness. Participants receive a single intravenous infusion of either HC034S or Erbitux at a dose of 250 mgm body surface area, with infusions lasting approximately 2 hours. Before infusion, participants are pre-medicated with antihistamines and corticosteroids at least one hour prior. The study uses a quadruple-blind design, and participants are randomly assigned to one of the two drug groups to ensure unbiased comparison. Throughout the study, participants are closely monitored for up to 29 days after dosing. Researchers measure several pharmacokinetic parameters, including the area under the concentration-time curve, maximum serum concentration, time to reach maximum concentration, clearance, half-life, and volume of distribution. Safety assessments include tracking adverse events, ECGs, lab tests, physical exams, and vital signs. The presence of anti-drug and neutralizing antibodies is also evaluated to understand immune response. The total participation duration spans about one month following the single infusion.
CONDITIONS
Brief Title
A Randomized, Double-Blind, Positive-Controlled, Parallel Pharmacokinetic Phase I Clinical Study of Cetuximab Injection Versus Erbitux in Healthy Male Subjects
Research Team
X
Xiaoai He
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here